4D Molecular (FDMT) analyst forecast and price target
Analyst forecast
Consensus of 10 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| B. Riley Securities | Initiated Coverage | Buy | $37.00 | Jul 31, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $36.00 | Jul 20, 2026 |
| Jefferies | Initiated Coverage | Buy | $21.00 from $40.00 | Mar 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $36.00 | Mar 20, 2026 |
| Chardan Capital | Maintained | Buy | $26.00 | Mar 19, 2026 |
| RBC Capital | Maintained | Outperform | $35.00 from $32.00 | Mar 19, 2026 |
| Barclays | Initiated Coverage | Overweight | $33.00 | Jan 28, 2026 |
| Chardan Capital | Maintained | Buy | $26.00 | Dec 18, 2025 |
| Chardan Capital | Maintained | Buy | $26.00 from $25.00 | Nov 11, 2025 |
| Barclays | Maintained | Overweight | $33.00 from $38.00 | Nov 11, 2025 |
| RBC Capital | Maintained | Outperform | $32.00 from $26.00 | Nov 11, 2025 |
| RBC Capital | Maintained | Outperform | $26.00 | Oct 21, 2025 |
| Chardan Capital | Maintained | Buy | $25.00 | Aug 12, 2025 |
| Roth Capital | Maintained | Buy | $38.00 from $44.00 | Aug 12, 2025 |
| Chardan Capital | Maintained | Buy | $25.00 | Aug 1, 2025 |
| Chardan Capital | Maintained | Buy | $25.00 | Jul 3, 2025 |
| Barclays | Maintained | Overweight | $38.00 from $45.00 | May 9, 2025 |
| Goldman Sachs | Maintained | Buy | $44.00 from $51.00 | May 9, 2025 |
| Chardan Capital | Maintained | Buy | $25.00 from $28.00 | May 9, 2025 |
| B of A Securities | Maintained | Buy | $40.00 from $42.00 | Mar 10, 2025 |
Frequently asked questions
Is FDMT a buy, sell, or hold?
Analysts covering 4D Molecular currently average a Buy rating: 8 buy, 2 hold and 0 sell, from 10 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on FDMT?
On Jul 31, 2026, B. Riley Securities initiated coverage of 4D Molecular at Buy with a price target of $37.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.